Precision treatment in colorectal cancer: Now and the future - Yau - 2019 - JGH Open - Wiley Online Library
4. Cancer colorectal métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
Lonsurf (Trifluridine plus Tipiracil): A New Oral Treatment Approved for Patients with Metastatic Colorectal Cancer
LONSURF® (trifluridine and tipiracil) tablets | Previously Treated mCRC Treatment | TAS-102 Efficacy
Combination extends OS in metastatic colorectal cancer
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study | British Journal of Cancer
Continued Avastin Extends Survival After 1st Progression in Colorectal Cancer - CancerConnect
Trifluridine/Tipiracil in Previously Treated Metastatic Colorectal Cancer - The ASCO Post
LONSURF® (trifluridine and tipiracil) tablets Efficacy | Previously Treated Metastatic GEJ and Gastric Cancer Treatment
Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia - Price - 2020 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Third-Line Treatment for Metastatic Colorectal Cancer | LONSURF® (trifluridine and tipiracil) tablets
Servier et Taiho Oncology présentent des données sur la survie globale de trifluridine/tipiracil (LONSURF®) en association avec le bevacizumab chez des patients atteints d'un cancer colorectal métastatique réfractaire... | Business Wire
Servier et Taiho Oncology présentent des données sur la survie globale de trifluridine/tipiracil (LONSURF®) en association avec le bevacizumab chez des patients atteints d'un cancer colorectal métastatique réfractaire... | Business Wire
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study | British Journal of Cancer
Benefits & Risks of Treatment | Metastatic Colorectal Cancer (mCRC)| Avastin® (bevacizumab)
NCCN® Guidelines for Metastatic Colon Cancer Treatment
How does chemo fit into my treatment plan? - Colontown University
Avastin and Lonsurf for Advanced Colorectal Cancer - NCI
La trifluridine plus le tipiracil et le bévacizumab est une nouvelle norme de soins pour le cancer colorectal métastatique réfractaire
How does chemo fit into my treatment plan? - Colontown University
TAS-102 plus bevacizumab: a new standard for metastatic colorectal cancer? - The Lancet Oncology
Current Oncology | Free Full-Text | A Systematic Review and Meta-Analysis of Trifluridine/Tipiracil plus Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Evidence from Real-World Series
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study | British Journal of Cancer
Taiho Oncology et Servier annoncent la publication dans le New England Journal of Medicine des données de l'étude pivot de phase 3 sur l'association trifluridine/tipiracil (LONSURF®) plus bévacizumab chez le patients atteint
Lonsurf® Treatment for Colorectal Cancer - CancerConnect
